Anika Therapeutics Inc (ANIK) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Anika Therapeutics Inc · Cost of Revenue

ANIK Cost of Revenue

Latest reported$45.65Mperiod endingJun 30, 2026

ANIK Cost of Revenue ($1.90M → $45.65M)

Annual cost of revenue

High-resolution chart · PNG

ANIK cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	49,012,000
Dec 31, 2024	43,909,000
Dec 31, 2023	38,260,000
Dec 31, 2022	40,607,000
Dec 31, 2021	64,851,000
Dec 31, 2020	61,431,000
Dec 31, 2019	28,747,000
Dec 31, 2018	31,280,000
Dec 31, 2017	27,364,000
Dec 31, 2016	24,027,000
Dec 31, 2015	21,053,000
Dec 31, 2014	20,930,318
Dec 31, 2013	22,765,404
Dec 31, 2012	28,988,621
Dec 31, 2011	26,783,738
Dec 31, 2010	23,826,604
Dec 31, 2009	13,670,228
Dec 31, 2008	13,188,516
Dec 31, 2007	11,880,989
Dec 31, 2006	11,117,861
Dec 31, 2005	11,144,000
Dec 31, 2004	9,949,000
Dec 31, 2003	8,005,000
Dec 31, 2002	8,108,695
Dec 31, 2001	8,228,751
Dec 31, 2000	8,672,819
Dec 31, 1999	5,300,000
Dec 31, 1998	5,200,000
Dec 31, 1997	4,400,000
Dec 31, 1996	700,000
Aug 31, 1995	2,800,000
Aug 31, 1994	3,700,000
Aug 31, 1993	1,900,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.